Regulatory T cells and human myeloid dendritic cells promote tolerance via programmed death ligand-1.
Immunotherapy using regulatory T cells (Treg) has been proposed, yet cellular and molecular mechanisms of human Tregs remain incompletely characterized. Here, we demonstrate that human Tregs promote the generation of myeloid dendritic cells (DC) with reduced capacity to stimulate effector T cell res...
Main Authors: | Shoba Amarnath, Carliann M Costanzo, Jacopo Mariotti, Jessica L Ullman, William G Telford, Veena Kapoor, James L Riley, Bruce L Levine, Carl H June, Timothy Fong, Noel L Warner, Daniel H Fowler |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2010-02-01
|
Series: | PLoS Biology |
Online Access: | http://europepmc.org/articles/PMC2814822?pdf=render |
Similar Items
-
Host-based Th2 cell therapy for prolongation of cardiac allograft viability.
by: Shoba Amarnath, et al.
Published: (2011-04-01) -
Rapamycin resistant murine th9 cells have a stable in vivo phenotype and inhibit graft-versus-host reactivity.
by: Courtney W Mangus, et al.
Published: (2013-01-01) -
Interactions of Cryptococcus with Dendritic Cells
by: Karen L. Wozniak
Published: (2018-03-01) -
Platelet concentrates modulate myeloid dendritic cell immune responses
by: Katrina K. Ki, et al.
Published: (2018-05-01) -
Induction of CD4+ T-cell responses by dendritic cells in vivo
by: Suri, R, et al.
Published: (1998)